iCo Therapeutics Inc  

(Public, CVE:ICO)   Watch this stock  
Find more results for cve:ico
0.390
-0.010 (-2.50%)
Apr 23 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.38 - 0.41
52 week 0.26 - 0.59
Open 0.40
Vol / Avg. 228,597.00/332,142.00
Mkt cap 30.83M
P/E     -
Div/yield     -
EPS -0.10
Shares 79.06M
Beta 0.89
Inst. own     -

Key stats and ratios

Q3 (Sep '13) 2012
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -148.58% -122.25%
Return on average equity -333.32% -153.68%
Employees 5 -
CDP Score - -

Address

760-777 Hornby Street
VANCOUVER, BC V6Z 1S4
Canada
+1-604-6029414 (Phone)
+1-604-6029699 (Fax)

Website links

Description

iCo Therapeutics Inc. (iCo) is a biotechnology company focused on the identification, development and commercialization of drug candidates that treat sight and life threatening diseases. The Company has in-licensed three product candidates: iCo-007, iCo-008 (also known as Bertilimumab), and an oral Amphotericin B delivery system, (Oral AmpB Delivery System) (formerly known as iCo-009). iCo-007 is a second generation antisense compound that reduces levels of a key protein associated with diabetic retinopathy. iCo-008 is a human monoclonal antibody that inhibits the development of severe allergic conjunctivitis, severe asthma, inflammatory bowel diseases and other indications. The oral AmpB Delivery System is for treatment of systemic fungal infections in immune-compromised patients (such as in human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS), cancer, transplant recipients and diabetics) and certain parasitical infections in the developing world.

Officers and directors

William W. Jarosz J.D. Independent Chairman of the Board
A. J Rae President, Chief Executive Officer, Director
W. John Meekison Chief Financial Officer, Corporate Secretary
Peter Hnik M.D. Chief Medical Officer
Age: 51
Richard W. Barker OBE Independent Director
Age: 64
Noel F. Hall Independent Director
Age: 45
Douglas G. Janzen Independent Director
Age: 41